Synthesis and Biological Evaluation of 5,6-Dihydro-benzo[c] acridin-7-ol Derivatives as Anti-Alzheimers Disease Drugs

Author(s): Jinpei Zhou, Xiaowen Hu, Huibin Zhang, Hai Qian, Wenlong Huang, Fan Qi, Yanchun Zhang

Journal Name: Letters in Drug Design & Discovery

Volume 6 , Issue 8 , 2009

Become EABM
Become Reviewer
Call for Editor


The multifactorial pathogenesis of Alzheimers disease (AD) suggests that drug treatments with two or more mechanisms of action, acting in a complementary manner, could be more efficacious to patients suffering from the disease. In an effort to develop new therapies to treat AD, a series of 5,6-dihydro-benzo[c]acridin-7-ol derivatives (5a-5q) were synthesized and evaluated for their AchE-inhibition and neuron-protection effects. Preliminary biological tests suggested that these compounds exhibited mild AchE-inhibition and commendable neuroprotection activities. Compounds 5m, 5n, 5p had noticeable neuron-protection as compared with tacrine and nimodipine.

Keywords: Alzheimer's disease, Cholinesterase inhibitors, Neuroprotection

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2009
Page: [623 - 628]
Pages: 6
DOI: 10.2174/157018009789353527
Price: $65

Article Metrics

PDF: 7